We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Par, Reliant Settle ANDA Suit Over Generic Rythmol

Law360 (April 21, 2009, 12:00 AM EDT) -- Par Pharmaceutical Inc. and Reliant Pharmaceuticals Inc. have settled patent litigation over Par's efforts to make a generic version of the heart arrhythmia treatment Rythmol SR.

Under the agreement, Par will...
To view the full article, register now.